A
Aurisco Pharmaceutical Co Ltd
SSE:605116
Aurisco Pharmaceutical Co Ltd
SSE:605116
Price:
22.97 CNY
1.55%
Updated:
Jun 3, 2024
Aurisco Pharmaceutical Co Ltd
Deferred Income Tax
|
Aurisco Pharmaceutical Co Ltd
Deferred Income Tax Peer Comparison
Comparables:
C
1093
H
3692
600436
600276
000538
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Deferred Income Tax
¥284.4k
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Deferred Income Tax
¥574.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
19%
|
CAGR 10-Years
36%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Deferred Income Tax
¥255m
|
CAGR 3-Years
28%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Deferred Income Tax
¥30m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-3%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Deferred Income Tax
¥83.6m
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Deferred Income Tax
¥74.8m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Deferred Income Tax?
Deferred Income Tax
284.4k
CNY
284.4k
CNY
Based on the financial report for Dec 31, 2023, Aurisco Pharmaceutical Co Ltd's Deferred Income Tax amounts to 284.4k CNY.
What is Aurisco Pharmaceutical Co Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
-14%
-14%
Over the last year, the Deferred Income Tax growth was -94%. The average annual Deferred Income Tax growth rates for Aurisco Pharmaceutical Co Ltd have been -49% over the past three years , -14% over the past five years .
You don't have any saved screeners yet
